Spiriva respimat and Prograf drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Spiriva respimat (tiotropium bromide) and Prograf (tacrolimus). Common drug interactions include immunosuppression among females and hyponatraemia among males.

The phase IV clinical study analyzes what interactions people have when they take Spiriva respimat and Prograf. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Spiriva respimat?

Spiriva respimat has active ingredients of tiotropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 9,788 Spiriva respimat users. Check the latest studies of Spiriva respimat.

What is Prograf?

Prograf has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 42,230 Prograf users. Check the latest studies of Prograf.



On Jul, 10, 2026

24 people who take Spiriva respimat and Prograf together, and have interactions are studied.

Spiriva respimat and Prograf drug interactions.

What are the common drug interactions of Spiriva Respimat and Prograf, by gender? *:

female:

  1. Immunosuppression
  2. Infection susceptibility increased
  3. Intra-abdominal haematoma (intra-abdominal localized swelling filled with blood)
  4. Marrow hyperplasia (increased bone marrow)
  5. Pulmonary mass
  6. Skin hypopigmentation (loss of skin colour)
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Upper limb fracture
  9. Infusion site bruising
  10. Lung transplant rejection (failure of lung transplant)

male:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Oedema peripheral (superficial swelling)

What are the common drug interactions of Spiriva Respimat and Prograf, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Immunosuppression
  2. Infection susceptibility increased
  3. Intra-abdominal haematoma (intra-abdominal localized swelling filled with blood)
  4. Marrow hyperplasia (increased bone marrow)
  5. Pulmonary mass
  6. Skin hypopigmentation (loss of skin colour)
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Upper limb fracture
  9. Rales (an abnormal respiratory sound characterized by fine crackles)
  10. Wheezing (a high-pitched whistling sound made while you breath)

60+:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Oedema peripheral (superficial swelling)

What are the existing conditions these people have? *

  1. High Blood Pressure: 16 people, 66.67%
  2. Type 2 Diabetes: 2 people, 8.33%
  3. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 8.33%
  4. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Spiriva respimat and Prograf?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Spiriva respimat and Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Spiriva respimat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Spiriva respimat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prograf and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tiotropium bromide and tacrolimus (the active ingredients of Spiriva respimat and Prograf, respectively), and Spiriva respimat and Prograf (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: